Lotilaner Elanco contains the active ingredient lotilaner which is an antiparasitic medication from the isoxazoline class. It works by inhibiting gamma–aminobutyric acid (GABA)-gated chloride channels, and so killing target parasites. It is licensed for use in dogs and cats and comes in the form of a chewable tablet.

The product has only just received a positive opinion for initial marketing on the 14th July 2022 so it will be a while before it is released onto the veterinary market. We will provide more information on the product when it becomes available.

If you have any specific questions regarding Lotilaner please contact our customer services on [email protected].

Written by: Dr. Nick Garside BVetMed MRCVS